Evidence map›Paper›PMID 36970470›Full record

ArticleIndian journal of anaesthesia2023

Recent advancements in total intravenous anaesthesia and anaesthetic pharmacology.

Sukhminder Jit Singh Bajwa, Stalin Vinayagam, Surekha Shinde, Shital Dalal, Jessy Vennel, Samridhi Nanda

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of anaesthesia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Sukhminder Jit Singh BajwaDepartment of Anaesthesiology and Intensive Care, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab, India.
Stalin VinayagamDepartment of Anaesthesiology and Critical Care, JIPMER, Puducherry, India.
Surekha ShindeDepartment of Anaesthesia, BJ Govt. Medical College and Sassoon Hospital, Pune, Maharashtra, India.
Shital DalalDepartment of Anaesthesiology, IGGMC, Nagpur, Maharashtra, India.
Jessy VennelDepartment of Anaesthesiology, MGM Medical College, Kamothe, Panvel, Navi Mumbai, Maharashtra, India.
Samridhi NandaDepartment of Anaesthesia, Critical Care and Pain Medicine, SMS Medical College, Jaipur, Rajasthan, India.
B. J. Medical College & Sassoon Hospital · INGian Sagar Medical College and Hospital · INIndira Gandhi Government Medical College & Hospital · INJawaharlal Institute of Post Graduate Medical Education and Research · INMahatma Gandhi Mission's Dental College and Hospital · INSawai ManSingh Medical College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Target-controlled infusion pumps and depth of anaesthesia monitors have made total intravenous anaesthesia (TIVA) easy, safe, and precise. The merits of TIVA were highlighted during the coronavirus disease 2019 (COVID-19) pandemic, confirming its potential further in the post-COVID clinical practice as well. Ciprofol and remimazolam are newer drugs that are being tried with a hope to upgrade the practice of TIVA. While research on safe and effective drugs continues, TIVA is being practised with a combination of drugs and adjuncts to overcome the disadvantages of each and to provide complete and balanced anaesthesia with additional benefits in recovery and pain relief postoperatively. Modulation of TIVA for the special population groups is still under process. Advancement in digital technology with mobile apps has increased the scope of TIVA in day-to-day use. The formulation and update of guidelines can establish a safe and efficient practice of TIVA.

Indexed as

Anaesthesiapharmacokineticspharmacologypropofol

Identifiers

PMID36970470
PMCPMC10034929
OpenAlexW4317433354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.